Product Monograph CEFTIN
... Clostridium difficile-associated disease (CDAD) has been reported with use of many antibacterial agents including CEFTIN® (see ADVERSE REACTIONS). CDAD may range in severity from mild diarrhea to fatal colitis. It is important to consider this diagnosis in patients who present with diarrhea, or symp ...
... Clostridium difficile-associated disease (CDAD) has been reported with use of many antibacterial agents including CEFTIN® (see ADVERSE REACTIONS). CDAD may range in severity from mild diarrhea to fatal colitis. It is important to consider this diagnosis in patients who present with diarrhea, or symp ...
pediatric handbook
... QUINOLONES Enteric GNB, including most ESBL and Pseudomonas. Levofloxacin also has excellent coverage against S. pneumoniae. Theoretical risk of development of arthropathy in children is based primarily on animal studies. The use of quinolones in situations of antibiotic resistance where no other ag ...
... QUINOLONES Enteric GNB, including most ESBL and Pseudomonas. Levofloxacin also has excellent coverage against S. pneumoniae. Theoretical risk of development of arthropathy in children is based primarily on animal studies. The use of quinolones in situations of antibiotic resistance where no other ag ...
AZACTAM® (aztreonam injection) - Products - Bristol
... AZACTAM (aztreonam injection) and other antibacterial drugs, AZACTAM should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or mod ...
... AZACTAM (aztreonam injection) and other antibacterial drugs, AZACTAM should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or mod ...
EryTab PI 03-A919-R2 Rev. July 2013 Final2
... not be treatable by ERY-TAB® or other antibacterial drugs in the future. Diarrhea is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued. Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stom ...
... not be treatable by ERY-TAB® or other antibacterial drugs in the future. Diarrhea is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued. Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stom ...
Ilotycin - Perrigo
... Pregnancy: Teratogenic effects —Pregnancy category B. Reproduction studies have been performed in rats, mice, and rabbits using erythromycin and its various salts and esters, at doses that were several multiples of the usual human dose. No evidence of harm to the fetus that appeared related to eryth ...
... Pregnancy: Teratogenic effects —Pregnancy category B. Reproduction studies have been performed in rats, mice, and rabbits using erythromycin and its various salts and esters, at doses that were several multiples of the usual human dose. No evidence of harm to the fetus that appeared related to eryth ...
Common Goat Medications and "Easy to Understand" Dosages
... Source: Veterinary Parasitology Reference Manual, 4th Ed; Foyert, 1997 * The labeled dose for fenbendazole products is 5mg/kg. Using twice the labeled dose is recommended in goats for routine worming. Using three times the labeled dose is recommended for treating tapworm infections. Exceeding the la ...
... Source: Veterinary Parasitology Reference Manual, 4th Ed; Foyert, 1997 * The labeled dose for fenbendazole products is 5mg/kg. Using twice the labeled dose is recommended in goats for routine worming. Using three times the labeled dose is recommended for treating tapworm infections. Exceeding the la ...
results - Pakistan Journal of Pharmaceutical Sciences
... Fredholm et al., 2013 reported accumulation of 1mg/kg P.O. (Per Oss) meloxicam in plasma up to 5 days and suggested a washout period of 10 days with meloxicam. In the present case on day 10 as the drug is almost completely eliminated from the body the values returned to normal. Musa and Ibrahim (201 ...
... Fredholm et al., 2013 reported accumulation of 1mg/kg P.O. (Per Oss) meloxicam in plasma up to 5 days and suggested a washout period of 10 days with meloxicam. In the present case on day 10 as the drug is almost completely eliminated from the body the values returned to normal. Musa and Ibrahim (201 ...
bacterial keratitis
... fluoroquinolones in head-to-head in vitro studies.49 The fourth-generation fluoroquinolones are not yet FDA-approved for the treatment of bacterial keratitis. Although there have been some concerns of increased perforation when utilizing fluoroquinolones in the management of severe bacterial keratit ...
... fluoroquinolones in head-to-head in vitro studies.49 The fourth-generation fluoroquinolones are not yet FDA-approved for the treatment of bacterial keratitis. Although there have been some concerns of increased perforation when utilizing fluoroquinolones in the management of severe bacterial keratit ...
Rocephin Prescribing Information
... Rocephin and other antibacterial drugs, Rocephin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial ...
... Rocephin and other antibacterial drugs, Rocephin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial ...
NEW ZEALAND DATA SHEET Ospamox
... Following single dose therapy of acute lower urinary tract infections, the urine should be cultured. A positive culture may be evidence of a complicated or upper urinary tract infection, and higher dose or prolonged course of treatment may be appropriate. Following administration of ampicillin to pr ...
... Following single dose therapy of acute lower urinary tract infections, the urine should be cultured. A positive culture may be evidence of a complicated or upper urinary tract infection, and higher dose or prolonged course of treatment may be appropriate. Following administration of ampicillin to pr ...
Nitrofurantoin revisited: a systematic review and meta
... The methodologically strongest studies date from the late 1990s and 2000s; these demonstrate overall equivalence between nitrofurantoin when given for 5 or 7 days and trimethoprim/sulfamethoxazole,15 – 19 ciprofloxacin,16 – 19 amoxicillin20 and fosfomycin,18,21 with clinical cure rates for the forme ...
... The methodologically strongest studies date from the late 1990s and 2000s; these demonstrate overall equivalence between nitrofurantoin when given for 5 or 7 days and trimethoprim/sulfamethoxazole,15 – 19 ciprofloxacin,16 – 19 amoxicillin20 and fosfomycin,18,21 with clinical cure rates for the forme ...
Clindamycin in 0.9% Sodium Chloride Injection
... with severe colitis which may end fatally, it should be reserved for serious infections where less toxic antimicrobial agents are inappropriate [see Indications and Usage (1)]. It should not be used in patients with nonbacterial infections such as most upper respiratory tract infections. C. difficil ...
... with severe colitis which may end fatally, it should be reserved for serious infections where less toxic antimicrobial agents are inappropriate [see Indications and Usage (1)]. It should not be used in patients with nonbacterial infections such as most upper respiratory tract infections. C. difficil ...
Suprax (cefixime)
... demonstrated some form of allergy, particularly to drugs. Severe Cutaneous Adverse Reactions: Severe cutaneous adverse reactions such as toxic epidermal necrolysis, Stevens-Johnson syndrome and drug rash with eosinophilia and systemic symptoms (DRESS) have been reported in some patients on SUPRAX. W ...
... demonstrated some form of allergy, particularly to drugs. Severe Cutaneous Adverse Reactions: Severe cutaneous adverse reactions such as toxic epidermal necrolysis, Stevens-Johnson syndrome and drug rash with eosinophilia and systemic symptoms (DRESS) have been reported in some patients on SUPRAX. W ...
Preparation : Vials contain 250mg aminophylline in 10mL
... How do I administer 0.9% or glucose 5%* and administer by intravenous infusion over 24 hours an intravenous using an infusion pump. Maximum concentration 25mg/mL. Maximum rate maintenance dose should not exceed 25mg/min. of aminophylline? Requires ECG and BP monitoring. ...
... How do I administer 0.9% or glucose 5%* and administer by intravenous infusion over 24 hours an intravenous using an infusion pump. Maximum concentration 25mg/mL. Maximum rate maintenance dose should not exceed 25mg/min. of aminophylline? Requires ECG and BP monitoring. ...
Vancomycin dosing
... Stable therapeutic levels cannot be achieved Patient has severe renal impairment or is on dialysis Patient is not clinically improving 6. Additional Monitoring 6.1 Renal function There is some evidence that high dose vancomycin is associated with a greater risk of renal toxicity.6,8 For patients wit ...
... Stable therapeutic levels cannot be achieved Patient has severe renal impairment or is on dialysis Patient is not clinically improving 6. Additional Monitoring 6.1 Renal function There is some evidence that high dose vancomycin is associated with a greater risk of renal toxicity.6,8 For patients wit ...
PRODUCT INFORMATION NUELIN SR TABLETS
... Higher levels may produce toxic effects. Toxic effects may also occur at therapeutic levels. When maximum response is required, dose levels should be individually titrated. Serum theophylline may be monitored to confirm that levels are within the therapeutic range. Monitoring is particularly recomme ...
... Higher levels may produce toxic effects. Toxic effects may also occur at therapeutic levels. When maximum response is required, dose levels should be individually titrated. Serum theophylline may be monitored to confirm that levels are within the therapeutic range. Monitoring is particularly recomme ...
BESIVANCE Potency and Broad-spectrum Activity for the Treatment of Bacterial Conjunctivitis
... used to manage ocular infections, including bacterial conjunctivitis, in large part because they have a broad spectrum of activity and are generally well tolerated. Despite overall effectiveness of the class, fluoroquinolone resistance is a growing problem, and there has been a concerning rise in th ...
... used to manage ocular infections, including bacterial conjunctivitis, in large part because they have a broad spectrum of activity and are generally well tolerated. Despite overall effectiveness of the class, fluoroquinolone resistance is a growing problem, and there has been a concerning rise in th ...
Full Product Information
... dosages of up to 100 mg/kg/day to achieve serum levels which inhibit the pathogen, but these high doses should be decreased as soon as possible. Adults with impaired hepatic or renal function, or both, may have reduced ability to metabolize and excrete the drug. In instances of impaired metabolic pr ...
... dosages of up to 100 mg/kg/day to achieve serum levels which inhibit the pathogen, but these high doses should be decreased as soon as possible. Adults with impaired hepatic or renal function, or both, may have reduced ability to metabolize and excrete the drug. In instances of impaired metabolic pr ...
antimicrobial use
... should be reserved for tertiary peritonitis or complicated abscesses where pretreatment with antibiotics (including recent hospitalizations) has led to the potential for documented or suspected resistant organisms. Anaerobic coverage should always be considered for abdominal/pelvic infections or ope ...
... should be reserved for tertiary peritonitis or complicated abscesses where pretreatment with antibiotics (including recent hospitalizations) has led to the potential for documented or suspected resistant organisms. Anaerobic coverage should always be considered for abdominal/pelvic infections or ope ...
PRODUCT MONOGRAPH PrLINCOCIN® Lincomycin injection USP
... Renal No serious renal abnormalities have been reported to date. The serum half-life of LINCOCIN is increased in those patients with impaired renal or hepatic function. Therefore, consideration should be given to reducing the frequency of administration in these patients. Patients with severe impair ...
... Renal No serious renal abnormalities have been reported to date. The serum half-life of LINCOCIN is increased in those patients with impaired renal or hepatic function. Therefore, consideration should be given to reducing the frequency of administration in these patients. Patients with severe impair ...
Full-Text PDF
... finally for the prophylaxis of recurrent urinary tract infections [1]. Due to its inability to achieve therapeutic blood concentrations, this compound has been relegated to a position of secondary importance. Thus, nitrofurantoin should never be administered to patients with acute bacterial pyelonep ...
... finally for the prophylaxis of recurrent urinary tract infections [1]. Due to its inability to achieve therapeutic blood concentrations, this compound has been relegated to a position of secondary importance. Thus, nitrofurantoin should never be administered to patients with acute bacterial pyelonep ...
Full Prescribing Information
... To reduce the development of drug-resistant bacteria and maintain the effectiveness of DORYX and other antibacterial drugs, DORYX should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information ...
... To reduce the development of drug-resistant bacteria and maintain the effectiveness of DORYX and other antibacterial drugs, DORYX should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information ...
Bilateral corneal perforation secondary to Pseudomonas keratitis in
... with or without a patch graft should be attempted6. If this fails or in the case of larger perforations, therapeutic penetrating keratoplasty will be needed after intensive topical, and sometimes systemic antibiotic therapy, for days in order to eradicate bacteria from the cornea as best as possible ...
... with or without a patch graft should be attempted6. If this fails or in the case of larger perforations, therapeutic penetrating keratoplasty will be needed after intensive topical, and sometimes systemic antibiotic therapy, for days in order to eradicate bacteria from the cornea as best as possible ...
digibind - GSK Australia
... TESTS). After treatment with Digibind, the serum potassium concentration may drop rapidly and must be monitored frequently, especially over the first several hours after Digibind is given (see LABORATORY TESTS). The elimination half-life in the setting of renal failure has not been clearly defined. ...
... TESTS). After treatment with Digibind, the serum potassium concentration may drop rapidly and must be monitored frequently, especially over the first several hours after Digibind is given (see LABORATORY TESTS). The elimination half-life in the setting of renal failure has not been clearly defined. ...
DOXYCYCLINE HYCLATE TABLETS, USP Rev. 06/11
... growth rate has been observed in prematures given oral tetracycline in doses of 25 mg/kg every 6 hours. This reaction was shown to be reversible when the drug was discontinued. Results of animal studies indicate that tetracyclines cross the placenta, are found in fetal tissues, and can have toxic ef ...
... growth rate has been observed in prematures given oral tetracycline in doses of 25 mg/kg every 6 hours. This reaction was shown to be reversible when the drug was discontinued. Results of animal studies indicate that tetracyclines cross the placenta, are found in fetal tissues, and can have toxic ef ...
Ciprofloxacin
Ciprofloxacin is an antibiotic used to treat a number of bacterial infections. This includes bone and joint infections, intra abdominal infections, certain type of infectious diarrhea, respiratory tract infections, skin infections, typhoid fever, and urinary tract infections, among others. For some infections it is used in addition to other antibiotics. It can be taken by mouth or used intravenously.Common side effects include nausea, vomiting, diarrhea, and rash. Ciprofloxacin increases the risk of tendon rupture and worsening muscle weakness in people with the neurological disorder myasthenia gravis. Rates of side effects appear to be higher than some groups of antibiotics such as cephalosporins but lower than others such as clindamycin. Studies in other animals raise concerns regarding use in pregnancy. No problems were identified; however, in the children of a small number of women who took the medication. It appears to be safe during breastfeeding. It is a second-generation fluoroquinolone with a broad spectrum of activity.Ciprofloxacin was introduced in 1987. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system. It is available as a generic medication and not very expensive. Wholesale it costs between 0.03 and 0.13 USD a dose. In the United States it is sold for about 0.40 USD per dose.